AGIO:NASDAQ
Agios Pharmaceuticals Inc
US$ 29.09
arrow_downward
-1.99%(-0.59) Siku 1
19 Nov, 14:20:46 GMT -5 · USD
search
Alama zote
| Alama | Bei | Tofauti | Tofauti ya asilimia |
|---|
insights_autoInatayarisha maarifa maarufu ya AGIO...
Fungua
US$ 29.93
Juu
US$ 30.35
Chini
US$ 29.03
Mtaji wa soko
1.74B
Wastani wa kiasi cha mauzo
1.18M
Kiasi cha mauzo ya hisa
elfu 195.28
Juu kwa wiki 52
US$ 44.07
Chini kwa wiki 52
US$ 23.02
EPS
-US$ 6.32
Beta
0.66
Hisa za wawekezaji
59.81M
Idadi ya wafanyakazi
540
Fungua
US$ 29.93
Juu
US$ 30.35
Chini
US$ 29.03
Mtaji wa soko
1.74B
Wastani wa kiasi cha mauzo
1.18M
Kiasi cha mauzo ya hisa
elfu 195.28
Juu kwa wiki 52
US$ 44.07
Chini kwa wiki 52
US$ 23.02
EPS
-US$ 6.32
Beta
0.66
Hisa za wawekezaji
59.81M
Idadi ya wafanyakazi
540
Habari
Kutoka kwenye vyanzo vya wavuti na washirika wa habari
TradingView
·
saa 1 iliyopita
Anthropic Jumps 27% in Record Debut, S&P 500 Eyes Sixth Straight Loss: Stock Market Today
ChartMill
·
saa 1 iliyopita
S&P 500 Unusual Volume Movers for Nov. 19, 2026
The Motley Fool
·
dakika 37 zilizopita
The S&P 500 Is Flashing Warning Signs. Here's Why Long-Term Investors Should Stay the Course.
Traders Union
·
saa 1 iliyopita
Charlie Bilello: S&P 500 declines 8% from October peak, largest pullback since March
Wasifu
Agios Pharmaceuticals Inc. is a publicly trading American pharmaceutical company pioneering therapies for genetically defined diseases, with a near-term focus on developing therapies for hemolytic anemias. The company was founded in 2008 by Lewis Cantley, Tak Mak and Craig Thompson. Agios is a Delaware corporation headquartered in Cambridge, Massachusetts. The company tendered an initial public offering in July 2013. Wikipedia
Kuhusu Agios Pharmaceuticals Inc
Afisa Mkuu Mtendaji (CEO)-
Wafanyakazi540
Lilianzishwa2008
Makao makuu-
SektaHealth Care
Sekta-
Tovutiagios.com